Pages that link to "Q61714016"
Jump to navigation
Jump to search
The following pages link to Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain (Q61714016):
Displaying 50 items.
- Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes (Q22337213) (← links)
- Fate of manganese associated with the inhalation of welding fumes: potential neurological effects (Q23914295) (← links)
- Loss of PINK1 attenuates HIF-1α induction by preventing 4E-BP1-dependent switch in protein translation under hypoxia (Q24337840) (← links)
- Role and regulation of ferritin H in rotenone-mediated mitochondrial oxidative stress (Q24644252) (← links)
- Neurodegenerative diseases: an overview of environmental risk factors (Q24815669) (← links)
- Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders (Q26826093) (← links)
- Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases (Q26827257) (← links)
- Iron dysregulation in Huntington's disease (Q26829932) (← links)
- New perspectives on oxidized genome damage and repair inhibition by pro-oxidant metals in neurological diseases (Q26996127) (← links)
- Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View (Q28084254) (← links)
- A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome (Q28210032) (← links)
- Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13 (Q28298493) (← links)
- Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells (Q28298685) (← links)
- Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease (Q28391762) (← links)
- The murine pantothenate kinase (Pank1) gene encodes two differentially regulated pantothenate kinase isozymes (Q28592377) (← links)
- Trace elements during primordial plexiform network formation in human cerebral organoids (Q28973587) (← links)
- Disease-toxicant interactions in Parkinson's disease neuropathology (Q29248297) (← links)
- Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. (Q30498692) (← links)
- Cytoprotective effect of acetyl-L-carnitine evidenced by analysis of gene expression in the rat brain. (Q30857723) (← links)
- Magnetic resonance imaging in parkinsonism (Q30987686) (← links)
- Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein (Q31120123) (← links)
- Modelling Ser129 phosphorylation inhibits membrane binding of pore-forming alpha-synuclein oligomers (Q31165000) (← links)
- Low selenium diet induces tyrosine hydroxylase enzyme in nigrostriatal system of the rat. (Q31673447) (← links)
- Iron accumulation in the substantia nigra in rats visualized by ultrasound (Q33178803) (← links)
- Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker (Q33233370) (← links)
- Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: implications for idiopathic and monogenetic forms (Q33283198) (← links)
- The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease (Q33543091) (← links)
- Management of early Parkinson's disease (Q33545295) (← links)
- Diagnosis of Parkinson’s Disease—Transcranial Sonography in Relation to MRI (Q33652092) (← links)
- Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients (Q33703477) (← links)
- Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein. (Q33771253) (← links)
- Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson's disease (Q33776138) (← links)
- Neurobehavioral aspects of antioxidants in aging (Q33922351) (← links)
- Acupuncture mechanism and redox equilibrium (Q33944455) (← links)
- Tracemetals, neuromelanin and neurodegeneration: An interesting area for research (Q33984927) (← links)
- Neuroprotection by the metabolic antioxidant alpha-lipoic acid (Q34063839) (← links)
- Iron transport in Parkinson's disease (Q34093439) (← links)
- The roles of iron in health and disease (Q34156115) (← links)
- An association study between Heme oxygenase-1 genetic variants and Parkinson's disease (Q34238382) (← links)
- Serum cholesterol and nigrostriatal R2* values in Parkinson's disease (Q34243731) (← links)
- PPARα controls the intracellular coenzyme A concentration via regulation of PANK1α gene expression (Q34267010) (← links)
- Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice (Q34328668) (← links)
- Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies (Q34372099) (← links)
- Single-channel electrophysiology reveals a distinct and uniform pore complex formed by α-synuclein oligomers in lipid membranes (Q34374310) (← links)
- Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease? (Q34378961) (← links)
- Oxidative damage to RNA: mechanisms, consequences, and diseases (Q34441389) (← links)
- Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system (Q34792120) (← links)
- Glutathione, iron and Parkinson's disease (Q34816461) (← links)
- Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach (Q34968452) (← links)
- Environmental factors in Parkinson's disease (Q34995010) (← links)